Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 21 04:00PM ET
4.22
Dollar change
+0.07
Percentage change
1.69
%
IndexRUT P/E- EPS (ttm)-1.28 Insider Own44.79% Shs Outstand48.30M Perf Week1.44%
Market Cap205.72M Forward P/E- EPS next Y-1.06 Insider Trans-7.99% Shs Float26.91M Perf Month-28.35%
Income-61.76M PEG- EPS next Q-0.32 Inst Own32.90% Short Float5.88% Perf Quarter87.56%
Sales82.85M P/S2.48 EPS this Y31.14% Inst Trans-3.45% Short Ratio2.99 Perf Half Y-41.14%
Book/sh2.63 P/B1.60 EPS next Y14.43% ROA-30.74% Short Interest1.58M Perf Year-64.18%
Cash/sh2.96 P/C1.42 EPS next 5Y- ROE-41.17% 52W Range1.04 - 11.86 Perf YTD-18.22%
Dividend Est.- P/FCF- EPS past 5Y-55.84% ROI-38.40% 52W High-64.42% Beta2.82
Dividend TTM- Quick Ratio11.47 Sales past 5Y87.82% Gross Margin84.58% 52W Low305.77% ATR (14)0.30
Dividend Ex-Date- Current Ratio12.11 EPS Y/Y TTM28.70% Oper. Margin-76.31% RSI (14)44.87 Volatility5.52% 6.88%
Employees250 Debt/Eq0.27 Sales Y/Y TTM26.54% Profit Margin-74.55% Recom2.67 Target Price5.12
Option/ShortYes / Yes LT Debt/Eq0.27 EPS Q/Q42.28% Payout- Rel Volume0.24 Prev Close4.15
Sales Surprise-7.32% EPS Surprise15.07% Sales Q/Q7.13% EarningsNov 07 AMC Avg Volume529.85K Price4.22
SMA20-4.86% SMA50-4.92% SMA200-24.96% Trades Volume126,581 Change1.69%
Date Action Analyst Rating Change Price Target Change
Sep-12-23Downgrade William Blair Outperform → Mkt Perform
Sep-12-23Downgrade Piper Sandler Overweight → Neutral $15 → $5.50
Sep-12-23Downgrade BofA Securities Neutral → Underperform $10 → $4.50
Aug-24-23Downgrade Morgan Stanley Overweight → Equal-Weight $12 → $8.40
Jul-10-23Downgrade Citigroup Buy → Neutral $15 → $9
Jan-06-23Upgrade Stifel Hold → Buy $10 → $15
Oct-04-22Initiated Needham Hold
Jul-26-22Initiated Stifel Hold $10
Feb-03-22Initiated William Blair Outperform
Jan-07-22Upgrade Morgan Stanley Equal-Weight → Overweight $36 → $27
Feb-21-24 10:25AM
Feb-14-24 04:05PM
Jan-23-24 04:05PM
Jan-14-24 05:25PM
Jan-08-24 04:05PM
09:15AM Loading…
Dec-28-23 09:15AM
Dec-18-23 04:05PM
Dec-08-23 08:05AM
Nov-13-23 03:40PM
Nov-12-23 09:40AM
Nov-07-23 04:05PM
Oct-26-23 05:30PM
Oct-24-23 04:05PM
Oct-19-23 04:05PM
Oct-12-23 04:05PM
08:30AM Loading…
Oct-03-23 08:30AM
Sep-12-23 09:53AM
02:55AM
Sep-11-23 04:06PM
04:05PM
Aug-30-23 04:05PM
Aug-03-23 06:35PM
04:05PM
Jul-24-23 09:55AM
Jul-20-23 04:05PM
08:30AM
Jul-17-23 12:00PM
Jun-21-23 08:30AM
Jun-09-23 04:05PM
May-23-23 08:30AM
09:55AM Loading…
May-09-23 09:55AM
May-06-23 11:30AM
May-04-23 06:45PM
04:05PM
May-01-23 04:05PM
Apr-26-23 04:05PM
Apr-20-23 04:05PM
Apr-19-23 01:57PM
Apr-13-23 04:05PM
Apr-11-23 05:22AM
Apr-03-23 04:05PM
Mar-30-23 08:00AM
Mar-23-23 11:25AM
Mar-14-23 11:22AM
Mar-13-23 05:25PM
04:05PM
Mar-09-23 08:30AM
Feb-23-23 04:05PM
Feb-22-23 04:05PM
Feb-14-23 07:10AM
Jan-26-23 08:30AM
Jan-09-23 04:20PM
01:15PM
Jan-04-23 10:00AM
Dec-29-22 09:10AM
Dec-13-22 01:09PM
Dec-08-22 08:30AM
Nov-22-22 08:30AM
Nov-16-22 05:21AM
Nov-10-22 05:35PM
04:05PM
Nov-03-22 10:00AM
08:30AM
Oct-20-22 05:20PM
Oct-14-22 10:51AM
Oct-04-22 03:38PM
Sep-29-22 08:30AM
Sep-28-22 08:30AM
Sep-16-22 08:00AM
Sep-13-22 03:01AM
Sep-02-22 08:00AM
Aug-25-22 04:05PM
Aug-23-22 08:03AM
Aug-16-22 12:23PM
08:01AM
Aug-12-22 02:31AM
Aug-11-22 04:05PM
Aug-10-22 10:25AM
Aug-09-22 09:55AM
Aug-04-22 10:00AM
Aug-02-22 09:55AM
Jul-29-22 08:48AM
Jul-28-22 08:00AM
Jul-19-22 04:26PM
Jul-18-22 09:55AM
Jul-06-22 01:55PM
May-31-22 08:00AM
May-19-22 08:00AM
May-10-22 04:05PM
May-07-22 10:40AM
Apr-29-22 08:00AM
Apr-20-22 04:05PM
Apr-14-22 04:05PM
Mar-26-22 02:31PM
Mar-25-22 07:08AM
12:00AM
Mar-24-22 04:05PM
04:04PM
Mar-16-22 08:00AM
Mar-03-22 04:05PM
Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Badawi PaulPresident and CEOJan 17Sale5.1615,91782,1955,319,539Jan 19 04:49 PM
Park Sam BoongChief Operating OfficerJan 17Sale5.165,44328,108100,735Jan 19 04:28 PM
HAYDEN JEREMY B.Chief Legal OfficerJan 17Sale5.164,53823,43410,318Jan 19 04:39 PM
Badawi DavidChief Technology OfficerJan 17Sale5.163,41417,6301,642,157Jan 19 04:43 PM
D1 Capital Partners L.P.10% OwnerDec 27Sale5.862,852,03616,712,9313,000,000Dec 29 08:30 PM
Encrantz StaffanDirectorNov 30Buy3.46140,777486,6381,012,150Dec 01 07:39 PM
Encrantz StaffanDirectorNov 29Buy3.503,22311,280871,373Dec 01 07:39 PM
Encrantz StaffanDirectorNov 28Buy3.46253,669877,137868,150Nov 28 08:32 PM
Encrantz StaffanDirectorNov 27Buy3.31246,331815,947614,481Nov 28 08:32 PM
Badawi DavidChief Technology OfficerNov 24Option Exercise0.11150,00016,5001,631,196Nov 28 08:16 PM
Encrantz StaffanDirectorNov 24Buy3.0921,85567,427368,150Nov 28 08:32 PM
Encrantz StaffanDirectorNov 22Buy2.5041,085102,708346,295Nov 22 06:19 PM
Encrantz StaffanDirectorNov 21Buy2.4868,477169,535305,210Nov 22 06:19 PM
Encrantz StaffanDirectorNov 20Buy2.2579,234178,189236,733Nov 22 06:19 PM
Encrantz StaffanDirectorNov 17Buy2.19126,664277,293157,499Nov 20 09:45 PM
Encrantz StaffanDirectorNov 16Buy2.0033967830,835Nov 20 09:45 PM
Encrantz StaffanDirectorNov 14Buy2.003,4626,91430,496Nov 16 05:44 PM
Park Sam BoongChief Operating OfficerSep 14Option Exercise1.9637,66873,82989,092Sep 15 06:33 PM